Retinoic acid receptor alpha drives cell cycle progression and is associated with increased sensitivity to retinoids in T-cell lymphoma

Peripheral T-cell lymphomas (PTCLs) are aggressive non-Hodgkin lymphomas with generally poor outcomes following standard therapy. Few candidate therapeutic targets have been identified to date. Retinoic acid receptor alpha (RARA) is a transcription factor that modulates cell growth and differentiati...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Wang, Xueju, Dasari, Surendra, Nowakowski, Grzegorz S., Lazaridis, Konstantinos N., Wieben, Eric D., Kadin, Marshall E., Feldman, Andrew L., Boddicker, Rebecca L.
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2017
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5432253/
https://ncbi.nlm.nih.gov/pubmed/28412739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15441
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares